Inventiva S.A. (IVA.PA) has a MoatMap StockRank of 26/100 based on Quality (22/100), Value (45/100), and Momentum (49/100) factor scores. The current signal is SELL. Inventiva S.A. is a small-cap healthcare company. Without more specific intelligence on its drug pipeline, competitive advantage, or clear pathway to profitability and high ROIC, it's impossible to establish a high-conviction thesis as a quality compounder with an un-copyable moat. Healthcare is often binary and speculative at this market cap.